Wenlong Wang

442 total citations
26 papers, 280 citations indexed

About

Wenlong Wang is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Wenlong Wang has authored 26 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Wenlong Wang's work include Thyroid Cancer Diagnosis and Treatment (7 papers), Cancer-related gene regulation (5 papers) and RNA modifications and cancer (4 papers). Wenlong Wang is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (7 papers), Cancer-related gene regulation (5 papers) and RNA modifications and cancer (4 papers). Wenlong Wang collaborates with scholars based in China, United States and United Kingdom. Wenlong Wang's co-authors include Xinying Li, Fada Xia, Shengyou Lin, Bisha Ding, Weiyang Lou, Peng Li, Yong Chen, Bo Jiang, Xin Du and Xinying Li and has published in prestigious journals such as Journal of Hazardous Materials, International Journal of Biological Macromolecules and Theranostics.

In The Last Decade

Wenlong Wang

24 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wenlong Wang China	10	198	130	50	32	29	26	280
Liye Fu China	11	216 1.1×	91 0.7×	72 1.4×	19 0.6×	18 0.6×	18	300
Jiaxiang Wang China	10	176 0.9×	122 0.9×	55 1.1×	28 0.9×	22 0.8×	24	295
Jiayan Lian China	8	229 1.2×	190 1.5×	32 0.6×	12 0.4×	17 0.6×	10	304
Jin‐Chun Qi China	10	181 0.9×	86 0.7×	23 0.5×	14 0.4×	26 0.9×	21	248
Leila Chaychi United States	5	142 0.7×	170 1.3×	27 0.5×	13 0.4×	23 0.8×	5	272
Xuanming Pan China	6	246 1.2×	123 0.9×	35 0.7×	21 0.7×	26 0.9×	7	362
Ugo Chianese Italy	10	149 0.8×	47 0.4×	54 1.1×	43 1.3×	39 1.3×	27	251
Zihan Yi China	10	202 1.0×	141 1.1×	33 0.7×	11 0.3×	29 1.0×	17	297
Qinghui Niu China	12	210 1.1×	160 1.2×	37 0.7×	21 0.7×	29 1.0×	27	365
Lili Du United States	10	160 0.8×	80 0.6×	92 1.8×	14 0.4×	11 0.4×	27	250

Countries citing papers authored by Wenlong Wang

Since Specialization

Citations

This map shows the geographic impact of Wenlong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenlong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenlong Wang more than expected).

Fields of papers citing papers by Wenlong Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenlong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenlong Wang. The network helps show where Wenlong Wang may publish in the future.

Co-authorship network of co-authors of Wenlong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenlong Wang. A scholar is included among the top collaborators of Wenlong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenlong Wang. Wenlong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Jiayu, Yujie Zhang, Zhichao Deng, et al.. (2025). Integrated cascade antioxidant nanozymes-Cu_5.4O@CNDs combat acute liver injury by regulating retinol metabolism. Theranostics. 15(12). 5592–5615. 1 indexed citations

Zhang, Yanmin, et al.. (2025). Study of the Drug Resistance Function of Ivermectin-Resistance-Related miRNAs in Haemonchus contortus. Acta Parasitologica. 70(1). 7–7. 1 indexed citations

Zhu, Jiayao, et al.. (2025). Impact of elevated temperature on immobilization of SeO42- and CrO42- in sulfoaluminate cement matrix. Journal of Hazardous Materials. 493. 138265–138265. 1 indexed citations

Zhang, Yuanyuan, Zhichao Deng, Yuanyuan Zhu, et al.. (2025). Metabolic reprogramming nanomedicine potentiates colon cancer sonodynamic immunotherapy by inhibiting the CD39/CD73/ADO pathway. Acta Pharmaceutica Sinica B. 15(5). 2655–2672. 1 indexed citations

Wang, Wenlong, Ying Ding, Hui Zhao, et al.. (2025). NSUN2–tRNAVal−CAC-axis-regulated codon-biased translation drives triple-negative breast cancer glycolysis and progression. Cellular & Molecular Biology Letters. 30(1). 100–100. 2 indexed citations

Wang, Wenlong, et al.. (2025). How do destination brand biographies influence tourist forgiveness in crisis contexts. Current Issues in Tourism. 1–24.

Chen, Lu, et al.. (2024). How Many Lymph Nodes are Enough in Thyroidectomy? A Cohort Study Based on Real-World Data. Annals of Surgical Oncology. 32(2). 1149–1157. 1 indexed citations

Chen, Lu, et al.. (2024). ASO Visual Abstract: How Many Lymph Nodes are Enough in Thyroidectomy? A Cohort Study Based on Real-World Data. Annals of Surgical Oncology. 32(3). 1727–1728.

Ding, Ying, et al.. (2024). YTHDF3-induced degradation of P4HA2 mRNA inhibits glycolysis in papillary thyroid cancer through Hippo signaling pathway. International Journal of Biological Macromolecules. 291. 139150–139150. 4 indexed citations

10.

Wang, Wenlong, et al.. (2023). m6A reader IGF2BP2 promotes lymphatic metastasis by stabilizing DPP4 in papillary thyroid carcinoma. Cancer Gene Therapy. 31(2). 285–299. 15 indexed citations

11.

Li, Peng, et al.. (2023). The impact of multifocality on lateral lymph node metastasis in papillary thyroid carcinoma. European Journal of Surgical Oncology. 49(9). 106944–106944. 3 indexed citations

12.

Li, Peng, et al.. (2023). The m⁵C methyltransferase NSUN2 promotes codon‐dependent oncogenic translation by stabilising tRNA in anaplastic thyroid cancer. Clinical and Translational Medicine. 13(11). e1466–e1466. 31 indexed citations

13.

Li, Peng, et al.. (2022). A Potential Four-Gene Signature and Nomogram for Predicting the Overall Survival of Papillary Thyroid Cancer. Disease Markers. 2022. 1–31. 5 indexed citations

14.

Xia, Fada, et al.. (2020). OTUD6B-AS1 Inhibits Viability, Migration, and Invasion of Thyroid Carcinoma by Targeting miR-183-5p and miR-21. Frontiers in Endocrinology. 11. 136–136. 20 indexed citations

15.

LIU, DIAN-LEI, et al.. (2020). Oridonin enhances the anti-tumor activity of gemcitabine towards pancreatic cancer by stimulating Bax- and Smac-dependent apoptosis. Translational Cancer Research. 9(7). 4148–4161. 6 indexed citations

16.

Wang, Wenlong, et al.. (2019). <p>Magnesemia: an independent risk factor of hypocalcemia after thyroidectomy</p>. Cancer Management and Research. Volume 11. 8135–8144. 16 indexed citations

17.

Xia, Fada, et al.. (2018). IQGAP1 plays an important role in the tumorigenesis and invasion of papillary thyroid cancer. Translational Cancer Research. 7(4). 1079–1091. 1 indexed citations

18.

Xia, Fada, Yong Chen, Bo Jiang, et al.. (2018). Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway. Cellular Physiology and Biochemistry. 50(5). 1659–1672. 55 indexed citations

19.

Wang, Wenlong, Wenying Yu, David Jou, et al.. (2016). A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells. Oncotarget. 7(11). 12917–12926. 38 indexed citations

20.

He, Yan, et al.. (2009). Knockdown of HBx by RNAi inhibits proliferation and enhances chemotherapy-induced apoptosis in hepatocellular carcinoma cells. Medical Oncology. 27(4). 1227–1233. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact